AgelessRx vs altRX
Two GLP-1 desks, one scoreboard. We put AgelessRx and altRX head-to-head on the published Brief Score — the same six factors, scored the same way.
AgelessRx
altRX
FDA warning letter, June 2026 — issued to Trinity HealthCare Supply, LLC dba altRx. See the FDA's warning letter database.
The verdict
AgelessRx takes this head-to-head.
AgelessRx scores 85 to 65 on our six-factor Brief Score — A longevity-leaning brand with one of the lowest tracked semaglutide stickers — but a thin disclosure on the rest.
That doesn't make altRX a bad call — it's best for readers who want the only platform offering all four brand-name glp-1s plus compounded. Weigh the six factors below against your own priorities before you decide.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.
Factor by factor
Both desks scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.
Price, coverage & the tracker
| AgelessRx | altRX | |
|---|---|---|
| Brief Score | 85/100 (B) | 65/100 (C) |
| Semaglutide | $139/mo | From $149/mo (starting dose, compounded) |
| Tirzepatide | Not disclosed | From $249/mo (starting dose, compounded) |
| Coverage | Not disclosed | Coverage not published |
| Brand-name access | Yes | Yes |
| Oral / sublingual | Injection only | Injection only |
| On the tracker | Stableprice stable | Newnew to the tracker, no prior reading |
AgelessRx: Low tracked semaglutide sticker; tirzepatide price still undisclosed.
altRX: New to the tracker on 1 August 2026. The published line reads From $149/mo (starting dose, compounded) at our first reading; there is no earlier reading of ours to compare it against yet.
● Not sold on either?
CoreAge Rx tops the whole ranking at 94/100.
The steadiest desk in the ranking: one flat, no-step-up price on both molecules, nationwide, and it hasn't moved.
Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.